Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14270060 | 1.00 | DPP4 (0.40) | DPP4DPP7 | |
| SCHEMBL245842 | 0.86 | — | — | |
| SCHEMBL5477828 | 0.86 | — | — | |
| SCHEMBL12203768 | 0.83 | — | — | |
| SCHEMBL22203127 | 0.83 | — | — | |
| SCHEMBL15325961 | 0.83 | — | — | |
| SCHEMBL16158122 | 0.83 | — | — | |
| SCHEMBL21285267 | 0.83 | — | — | |
| SCHEMBL12203388 | 0.83 | — | — | |
| SCHEMBL19451382 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3541803-B1 | TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC (US) | 2020-12-23 | — | — | EP | disclosed |
| EP-3541805-B1 | HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS | AMGEN INC (US) | 2020-10-14 | — | — | EP | disclosed |
| EP-1627901-B1 | PRIMER, CONDUCTOR FOIL WITH RESIN, LAMINATE AND PROCESS FOR PRODUCING THE LAMINATE | HITACHI CHEMICAL CO LTD (JP) | 2020-02-19 | — | — | EP | disclosed |
| WO-2018097945-A1 | HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS | AMGEN INC. (US) | 2018-05-31 | — | — | WO | disclosed |
| WO-2018093579-A1 | TRIAZOLE PHENYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2018-05-24 | — | — | WO | disclosed |
| WO-2018093580-A1 | TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2018-05-24 | — | — | WO | disclosed |
| WO-2017192485-A1 | HETEROCYCLIC TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| US-9795927-B2 | Manufacturing carbon molecular sieve membranes using a pyrolysis atmosphere comprising sulfur-containing compounds | L'Air Liquide Société Anonyme Pour L'Étude Et L'Exploitation Des Procedes Georges (FR) | 2017-10-24 | — | — | US | disclosed |
| US-20160184776-A1 | MANUFACTURING CARBON MOLECULAR SIEVE MEMBRANES USING A PYROLYSIS ATMOSPHERE COMPRISING SULFUR-CONTAINING COMPOUNDS | AMERICAN AIR LIQUIDE, INC. | 2016-06-30 | — | — | US | disclosed |
| US-20160184775-A1 | MANUFACTURING CARBON MOLECULAR SIEVE MEMBRANES USING A PYROLYSIS ATMOSPHERE COMPRISING SULFUR-CONTAINING COMPOUNDS | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2016-06-30 | — | — | US | disclosed |
| EP-1939692-A2 | Method for preparation of lithographic printing plate | FUJIFILM Corporation (JP) | 2008-07-02 | — | — | EP | disclosed |
| US-20080051583-A1 | NOVEL INTERMEDIATE COMPOUNDS USEFUL IN THE PRODUCTION OF DIARYLCYCLOALKYL DERIVATIVES | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-02-28 | — | — | US | disclosed |
| US-20070255064-A1 | Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-01 | — | — | US | disclosed |
| US-20070185297-A1 | Primer, conductor foil with resin, laminated sheet and method of manufacturing laminated sheet | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070185297-A1 | Primer, conductor foil with resin, laminated sheet and method of manufacturing laminated sheet | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-7156907-B2 | Multimeric dye structures | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2007-01-02 | — | — | US | disclosed |
| WO-2001030745-A1 | ANTHRANILIC ACID DERIVATIVES AS INHIBITORS OF THE CGMP-PHOSPHODIESTERASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-03 | — | — | WO | disclosed |
| EP-0634381-B1 | Olefin oligomerization process | AMOCO CORP (US) | 1998-09-02 | — | — | EP | disclosed |
| US-5396013-A | Boron trifluoride, proton promoter and polyether | ALBEMARLE CORPORATION (US) | 1995-03-07 | — | — | US | disclosed |
| EP-0634381-A1 | Olefin oligomerization process | ALBEMARLE CORPORATION (US) | 1995-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070255064-A1 | Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids | CBR3, SCO2, PRMT5 | DPP4 4707/4885DPP7 4776/4885 |
| US-20080051583-A1 | NOVEL INTERMEDIATE COMPOUNDS USEFUL IN THE PRODUCTION OF DIARYLCYCLOALKYL DERIVATIVES | PPARG, PPARD, PPARA | DPP4 1546/4885DPP7 1371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.